Literature DB >> 6995129

Pharmacokinetics of chlormethiazole in healthy volunteers and patients with cirrhosis of the liver.

P J Pentikäinen, P J Neuvonen, K G Jostell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6995129     DOI： 10.1007/bf00625801

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  23 in total

1.  Letter: Intrahepatic portasystemic shunting in cirrhotic patients.

Authors:  G Gross; C V Perrier
Journal:  N Engl J Med       Date:  1975-11-13       Impact factor: 91.245

2.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

3.  Pharmacokinetics of chlormethiazole in humans.

Authors:  R G Moore; E J Triggs; C A Shanks; J Thomas
Journal:  Eur J Clin Pharmacol       Date:  1975-06-13       Impact factor: 2.953

Review 4.  Drug disposition and liver disease.

Authors:  G R Wilkinson; S Schenker
Journal:  Drug Metab Rev       Date:  1975       Impact factor: 4.518

5.  Assessment of aminopyrine metabolism in man by breath analysis after oral administration of 14C-aminopyrine. Effects of phenobarbital, disulfiram and portal cirrhosis.

Authors:  G W Hepner; E S Vesell
Journal:  N Engl J Med       Date:  1974-12-26       Impact factor: 91.245

6.  Clearance and biologic half-life as indices of intrinsic hepatic metabolism.

Authors:  D Perrier; M Gibaldi
Journal:  J Pharmacol Exp Ther       Date:  1974-10       Impact factor: 4.030

7.  Pentazocine binding to blood cells and plasma proteins.

Authors:  M Ehrnebo; S Agurell; L O Boréus; E Gordon; U Lönroth
Journal:  Clin Pharmacol Ther       Date:  1974-09       Impact factor: 6.875

8.  [Death in alcoholic delirium under Distraneurin medication].

Authors:  D Hossfeld
Journal:  Med Welt       Date:  1969-08-16

9.  Effect of cirrhosis of the liver on the pharmacokinetics of chlormethiazole.

Authors:  P J Pentikainen; P J Neuvonen; S Tarpila; E Syvälahti
Journal:  Br Med J       Date:  1978-09-23

10.  Deaths in connection with chlormethiazole (heminevrin) therapy.

Authors:  P J Pentikäinen; V V Valtonen; T A Miettinen
Journal:  Int J Clin Pharmacol Biopharm       Date:  1976-10
View more
  18 in total

1.  A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance.

Authors:  Trevor N Johnson; Koen Boussery; Karen Rowland-Yeo; Geoffrey T Tucker; Amin Rostami-Hodjegan
Journal:  Clin Pharmacokinet       Date:  2010-03       Impact factor: 6.447

Review 2.  Guide to drug dosage in hepatic disease.

Authors:  N M Bass; R L Williams
Journal:  Clin Pharmacokinet       Date:  1988-12       Impact factor: 6.447

Review 3.  Dose adjustment in patients with liver disease.

Authors:  Fabiola Delcò; Lydia Tchambaz; Raymond Schlienger; Jürgen Drewe; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  Accumulation of chlormethiazole during intravenous infusion.

Authors:  D J Robson; C Blow; P Gaines; R J Flanagan; J A Henry
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

5.  The protective action of chlormethiazole against ischaemia-induced neurodegeneration in gerbils when infused at doses having little sedative or anticonvulsant activity.

Authors:  A J Cross; J A Jones; M Snares; K G Jostell; U Bredberg; A R Green
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

6.  Pharmacokinetics and sedative effects in healthy subjects and subjects with impaired liver function after continuous infusion of clomethiazole.

Authors:  Carina Centerholt; Marianne Ekblom; Tomas Odergren; Olof Borgå; Gabriela Popescu; Karl-Heinz Molz; Andrea Couturier; Angelika Weil
Journal:  Eur J Clin Pharmacol       Date:  2003-05-07       Impact factor: 2.953

Review 7.  Effect of hepatic insufficiency on pharmacokinetics and drug dosing.

Authors:  R K Verbeeck; Y Horsmans
Journal:  Pharm World Sci       Date:  1998-10

Review 8.  Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.

Authors:  Roger K Verbeeck
Journal:  Eur J Clin Pharmacol       Date:  2008-09-02       Impact factor: 2.953

Review 9.  Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation.

Authors:  Chantal Schlatter; Sabin S Egger; Lydia Tchambaz; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

10.  Comparative pharmacokinetics and cardiovascular effects of tiapamil in healthy volunteers and patients with hepatic cirrhosis.

Authors:  P H Hinderling; M Eckert; S Gasic; H G Eichler; R Pötzi; P Heizmann
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.